NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic

  • Written by ACN Newswire

image

OCALA, FL / ACCESSWIRE, Feb 18, 2020 - (ACN Newswire) - AIM ImmunoTech (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today provided its stockholders with an update on its efforts to develop Ampligen as a protective...

Read more: AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the...